Gene · 51548
Papers4,574
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,574
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chronic obstructive pulmonary disease: in-depth analysis of microbiota association and innovative prevention and treatment approaches from the gut-lung axis perspective. | Front Immunol | 2025 | 40808958 | PubTator, text mining | PubMed |
| Glucocorticoid-Mediated Skeletal Muscle Atrophy: Molecular Mechanisms and Potential Therapeutic Targets. | Int J Mol Sci | 2025 | 40806744 | PubTator, text mining | PubMed |
| SIRT6 Attenuates ER Stress-Associated Mucus Hypersecretion via Regulation of NRF2 in Asthma Models. | FASEB J | 2025 | 40779353 | PubTator, text mining | PubMed |
| Hyperactivation of the m6A demethylase FTO to down-regulate SLC7A11/xCT-mediated redox homeostasis and epigenetic remodeling in facial infiltrating lipomatosis. | Free Radic Biol Med | 2025 | 40769313 | PubTator, text mining | PubMed |
| CircZNF418 Prevents Intervertebral Disc Degeneration by Targeting the HuR/SIRT6 Axis to Protect Against Oxidative Stress-Induced Ferroptosis and Senescence. | IUBMB Life | 2025 | 40767364 | PubTator, text mining | PubMed |
| Mechanisms and therapeutic strategies linking mesenchymal stem cells senescence to osteoporosis. | Front Endocrinol (Lausanne) | 2025 | 40761817 | PubTator, text mining | PubMed |
| RNA Epigenetics in Cancer: Current Knowledge and Therapeutic Implications. | MedComm (2020) | 2025 | 40761481 | PubTator, text mining | PubMed |
| Role of SIRT6 in Chronic Periodontitis and Osteogenic Differentiation of Periodontal Ligament Stem Cells. | Int Dent J | 2025 | 40759069 | PubTator, text mining | PubMed |
| Exosomes in ovarian cancer: Impact on drug resistance and advances in SERS detection techniques. | J Pharm Anal | 2025 | 40757000 | PubTator, text mining | PubMed |
| Anoikis and NETosis in colorectal cancer liver metastasis: the relationship and perspectives. | Biochim Biophys Acta Rev Cancer | 2025 | 40744394 | PubTator, text mining | PubMed |
| Altered albumin/neutrophil to lymphocyte ratio are associated with all-cause and cardiovascular mortality for advanced cardiovascular-kidney-metabolic syndrome. | Front Nutr | 2025 | 40740647 | PubTator, text mining | PubMed |
| Regulation and intervention of stem cell differentiation by long non-coding RNAs: Mechanisms and therapeutic potential. | World J Stem Cells | 2025 | 40740526 | PubTator, text mining | PubMed |
| Necroptosis in cancer: insight from epigenetic, post-transcriptional and post-translational modifications. | J Hematol Oncol | 2025 | 40739259 | PubTator, text mining | PubMed |
| RNA m6A modification: a key regulator in normal and malignant processes. | Cell Investig | 2025 | 40734692 | PubTator, text mining | PubMed |
| Sirtuins in Central Nervous System Tumors-Molecular Mechanisms and Therapeutic Targeting. | Cells | 2025 | 40710366 | PubTator, text mining | PubMed |
| Sirtuins in mitophagy: key gatekeepers of mitochondrial quality. | Mol Cell Biochem | 2025 | 40705152 | PubTator, text mining | PubMed |
| In silico-guided exploration of SIRT6 modulation: Discovery of new fragments hits inhibitors. | J Mol Graph Model | 2025 | 40651357 | PubTator, text mining | PubMed |
| Icariin as a therapeutic agent in breast cancer: modulating apoptosis and suppressing proliferation. | J Complement Integr Med | 2025 | 40618228 | PubTator, text mining | PubMed |
| The possible role of hsa_circ_0049356 and hsa-miR-338-3p in systemic lupus erythematosus disease. | Mol Biol Rep | 2025 | 40608140 | PubTator, text mining | PubMed |
| miR-769-5p has diagnostic value in acute kidney injury in intensive care unit patients and mediates disease development by targeting SIRT6. | BMC Nephrol | 2025 | 40597884 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51548/papers?page=11